Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Debt / NOTE 1.750% 6/1
-
Market price (% of par)
-
115.06%
-
Total 13F principal
-
$327,652,163
-
Principal change
-
+$11,609,261
-
Total reported market value
-
$376,803,322
-
Number of holders
-
45
-
Value change
-
+$15,542,312
-
Number of buys
-
17
-
Number of sells
-
25
Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 as of Q4 2014
As of 31 Dec 2014,
ACORDA THERAPEUTICS INC - NOTE 1.750% 6/1 was held by
45 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$327,652,163
in principal (par value) of the bond.
The largest 10 bondholders included
BAKER BROS. ADVISORS LP, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, Calamos Advisors LLC, Fore Research & Management, LP, Davidson Kempner Capital Management LP, SYMPHONY ASSET MANAGEMENT LLC, Ameriprise Financial Inc, CAMDEN ASSET MANAGEMENT L P /CA, Polar Securities Inc., and Linden Advisors LP.
This page lists
45
institutional bondholders reporting positions
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.